Sort
261,768 grants matching “gene therapy”
Safe and effective anti CD154 antibodies for therapeutic intervention
$1,000,000Jay L Rothstein · Immunext, Inc. · R44 · FY2015 · AI
Core Center for Stem Cell and Transplantation Biology
$1,000,000Beverly J Torok-Storb · Fred Hutchinson Cancer Research Center · U54 · FY2015 · DK
Hemophilia Point-of-Care Monitoring Device and App
$1,000,000Eugene Yan-Ho Chan · Dna Medicine Institute · R44 · FY2025 · HL
Human Stem Cell Model of Niemann Pick Type C
$1,000,000Lawrence S Goldstein · University Of California, San Diego · RC1 · FY2010 · NS
Development of GPER Agonists as Cancer Therapeutics
$1,000,000Tina Garyantes · Linnaeus Therapeutics, Llc · R44 · FY2019 · CA
Optimization of novel pyranopyridine efflux pump inhibitors
$1,000,000Timothy J Opperman · Microbiotix, Inc · R44 · FY2021 · AI
Development of the RXR agonist IRX4204 to treat Multiple Sclerosis and other Immune related Diseases
$1,000,000Rosh Chandraratna · Io Therapeutics, Inc. · R44 · FY2017 · AI
HPMI: Host Pathogen Mapping Initiative
$1,000,000Nevan J Krogan · University Of California, San Francisco · U19 · FY2021 · AI
Developing a bank of purified myeloid progenitor cells as a bridging therapy for transient pancytopenia resulting from radiation injury
$1,000,000Brian H. Johnstone · Ossium Health, Inc. · R44 · FY2025 · AI
Development of the NephroPlate: A high-throughput kidney-on-a-chip platform for identifying chronic kidney disease therapies
$1,000,000Kristin M Bircsak · Mimetas Us, Inc. · R44 · FY2022 · DK
Scaling function-first antibody discovery leveraging memory B cells
$1,000,000Joseph De Rutte · Partillion Bioscience Corporation · R44 · FY2025 · AI
Novel therapy for alcoholic liver disease-associated hepatorenal syndrome
$1,000,000Mani Subramanian · Mitopower Llc · U44 · FY2022 · AA
Novel extra cellular RNA-based combinatorial RNA inhibition therapy
$1,000,000Anil K Sood · University Of Tx Md Anderson Can Ctr · UH3 · FY2017 · TR
Novel Targeted Nanomedicine Delivering MicroRNA-30-5p ReplacementTherapy for Multi-drug Resistant Cancer Treatment
$1,000,000Robert F Place · Mirecule, Inc. · U44 · FY2020 · CA
Chemical Stabilization of shRNAs and their development as hepatitis C drugs
$1,000,000Brian H. Johnston · Somagenics, Inc. · R44 · FY2011 · AI
SIRPant Technology for anti-Cancer Immunity
$999,999Nathanael McCurley · Bobcatbio, Inc. · R42 · FY2024 · CA
A method for accurate and sensitive detection of HIV drug-resistant minority variants
$999,999Gary P. Wang · Medosome Biotec, Llc · R42 · FY2022 · AI
Targeting glioblastoma stem-like cells with custom-designed viral vectors
$999,999Darin J Falk · Lacerta Therapeutics, Inc. · R42 · FY2020 · CA
Targeting glioblastoma stem-like cells with custom-designed viral vectors
$999,999Darin J Falk · Lacerta Therapeutics, Inc. · R42 · FY2019 · CA
Spatial and single cell analysis of tumor microenvironment by seqFISH+
$999,999Kirsten Frieda · Spatial Genomics, Inc. · R44 · FY2021 · CA
Augmenting the CMDKP with advanced features for understanding biological mechanisms
$999,999Jason Flannick · Broad Institute, Inc. · UM1 · FY2025 · DK
Antibody-Biocide Fusions to Control Cryptosporidium
$999,999Michael Imboden · Iogenetics, Llc · R44 · FY2011 · AI
Antibody-Biocide Fusions to Control Cryptosporidium
$999,999Michael Imboden · Iogenetics, Llc · R44 · FY2010 · AI
Ferritin-Based Molecular Imaging of Cardiac Stem Cell Therapy
$999,999Charles E Murry · University Of Washington · RC1 · FY2010 · HL
Spatial and single cell analysis of tumor microenvironment by seqFISH+
$999,999Kirsten Frieda · Spatial Genomics, Inc. · R44 · FY2020 · CA